PUS7 and non-small cell lung carcinoma: Further multivariate analysis data also confirmed that gender, clinical stage, adjuvant chemotherapy, and PUS7 expression were independent prognostic risk factors for NSCLC patients after surgery (P all < 0.05, Table 2).